Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Idiazole vs Pariet (Rabeprazole) in Healthy Adults
NCT02605395Phase 4Completed
- Sponsor
- GSK
- Start
- Mar 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rabeprazole in gastroesophageal reflux disease (GERD), sponsored by GSK. Started Mar 2014; status: completed.
02
Drugs
rabeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02605395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02605395.